Expression of influenza M2e-NP recombinant fusion protein in Escherichia coli BL21 (DE3) and its binding to antibodies

The current influenza vaccines only confer protection against the circulating influenza subtypes, therefore universal vaccines are needed to prevent upcoming influenza outbreaks caused by emerging influenza subtypes. The extracellular domain of influenza A M2 protein (M2e) is highly conserved among...

Full description

Bibliographic Details
Main Authors: Tan, Mei Peng, Alitheen, Noorjahan, Tan, Wen Siang, Yap, Wei Boon
Format: Article
Published: Multidisciplinary Digital Publishing Institute 2022
_version_ 1825938539034968064
author Tan, Mei Peng
Alitheen, Noorjahan
Tan, Wen Siang
Yap, Wei Boon
author_facet Tan, Mei Peng
Alitheen, Noorjahan
Tan, Wen Siang
Yap, Wei Boon
author_sort Tan, Mei Peng
collection UPM
description The current influenza vaccines only confer protection against the circulating influenza subtypes, therefore universal vaccines are needed to prevent upcoming influenza outbreaks caused by emerging influenza subtypes. The extracellular domain of influenza A M2 protein (M2e) is highly conserved among different subtypes of influenza A viruses, and it is able to elicit protective immunity against the viruses. The influenza nucleoprotein (NP) was used to display the M2e in this study due to its promising T-cell response and adjuvanticity. The M2e gene was fused to the 5′-end of the NP gene and then cloned into pRSET B vector. The DNA sequencing analysis revealed six point mutations in the M2e-NP fusion gene, including one mutation in the M2e peptide and five mutations in the NP. The mutations were reverted using PCR site-directed mutagenesis. The recombinant plasmids (pRSET B-M2e-NP and pRSET B-mM2e-NP) were introduced into Escherichia coli (E. coli) BL21 (DE3) for protein expression. The mutated and non-mutated proteins were subsequently expressed and named mM2e-NP and M2e-NP, respectively. The expression of mM2e-NP and M2e-NP was not affected by the mutations. The binding of anti-M2e antibody to the purified native mM2e-NP and M2e-NP also remained active. However, when the anti-NP antibody was tested, the signal produced by mM2e-NP was very weak. The results implied that the amino acid changes in the NP had adversely impacted on the conformation of mM2e-NP and subsequently affected the antibody binding. In light of the remarkable antibody binding to the M2e-NP fusion protein, this study highly recommends the potential of M2e-NP as a universal influenza vaccine candidate.
first_indexed 2024-03-06T11:15:17Z
format Article
id upm.eprints-101437
institution Universiti Putra Malaysia
last_indexed 2024-03-06T11:15:17Z
publishDate 2022
publisher Multidisciplinary Digital Publishing Institute
record_format dspace
spelling upm.eprints-1014372023-10-04T07:01:33Z http://psasir.upm.edu.my/id/eprint/101437/ Expression of influenza M2e-NP recombinant fusion protein in Escherichia coli BL21 (DE3) and its binding to antibodies Tan, Mei Peng Alitheen, Noorjahan Tan, Wen Siang Yap, Wei Boon The current influenza vaccines only confer protection against the circulating influenza subtypes, therefore universal vaccines are needed to prevent upcoming influenza outbreaks caused by emerging influenza subtypes. The extracellular domain of influenza A M2 protein (M2e) is highly conserved among different subtypes of influenza A viruses, and it is able to elicit protective immunity against the viruses. The influenza nucleoprotein (NP) was used to display the M2e in this study due to its promising T-cell response and adjuvanticity. The M2e gene was fused to the 5′-end of the NP gene and then cloned into pRSET B vector. The DNA sequencing analysis revealed six point mutations in the M2e-NP fusion gene, including one mutation in the M2e peptide and five mutations in the NP. The mutations were reverted using PCR site-directed mutagenesis. The recombinant plasmids (pRSET B-M2e-NP and pRSET B-mM2e-NP) were introduced into Escherichia coli (E. coli) BL21 (DE3) for protein expression. The mutated and non-mutated proteins were subsequently expressed and named mM2e-NP and M2e-NP, respectively. The expression of mM2e-NP and M2e-NP was not affected by the mutations. The binding of anti-M2e antibody to the purified native mM2e-NP and M2e-NP also remained active. However, when the anti-NP antibody was tested, the signal produced by mM2e-NP was very weak. The results implied that the amino acid changes in the NP had adversely impacted on the conformation of mM2e-NP and subsequently affected the antibody binding. In light of the remarkable antibody binding to the M2e-NP fusion protein, this study highly recommends the potential of M2e-NP as a universal influenza vaccine candidate. Multidisciplinary Digital Publishing Institute 2022-12-01 Article PeerReviewed Tan, Mei Peng and Alitheen, Noorjahan and Tan, Wen Siang and Yap, Wei Boon (2022) Expression of influenza M2e-NP recombinant fusion protein in Escherichia coli BL21 (DE3) and its binding to antibodies. Vaccines, 10 (12). art. no. 10122066. pp. 1-17. ISSN 2076-393X https://www.mdpi.com/2076-393X/10/12/2066 10.3390/vaccines10122066
spellingShingle Tan, Mei Peng
Alitheen, Noorjahan
Tan, Wen Siang
Yap, Wei Boon
Expression of influenza M2e-NP recombinant fusion protein in Escherichia coli BL21 (DE3) and its binding to antibodies
title Expression of influenza M2e-NP recombinant fusion protein in Escherichia coli BL21 (DE3) and its binding to antibodies
title_full Expression of influenza M2e-NP recombinant fusion protein in Escherichia coli BL21 (DE3) and its binding to antibodies
title_fullStr Expression of influenza M2e-NP recombinant fusion protein in Escherichia coli BL21 (DE3) and its binding to antibodies
title_full_unstemmed Expression of influenza M2e-NP recombinant fusion protein in Escherichia coli BL21 (DE3) and its binding to antibodies
title_short Expression of influenza M2e-NP recombinant fusion protein in Escherichia coli BL21 (DE3) and its binding to antibodies
title_sort expression of influenza m2e np recombinant fusion protein in escherichia coli bl21 de3 and its binding to antibodies
work_keys_str_mv AT tanmeipeng expressionofinfluenzam2enprecombinantfusionproteininescherichiacolibl21de3anditsbindingtoantibodies
AT alitheennoorjahan expressionofinfluenzam2enprecombinantfusionproteininescherichiacolibl21de3anditsbindingtoantibodies
AT tanwensiang expressionofinfluenzam2enprecombinantfusionproteininescherichiacolibl21de3anditsbindingtoantibodies
AT yapweiboon expressionofinfluenzam2enprecombinantfusionproteininescherichiacolibl21de3anditsbindingtoantibodies